Skip to main content

Smokoff Timothy's Form 4 filing

Viemed Healthcare, Inc. (VMD) · filed Aug 19, 2026

Accession no.
0001782064-26-000007
Filed
Aug 19, 2026, 4:30 PM ET
Trade date
Aug 17-19, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 4 derivative transactions. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Smokoff TimothyCIK 0001782064Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 19, 2026Common SharesMOption exerciseAcquired+15,029–F1–90,547Direct
Aug 19, 2026Common SharesMOption exerciseAcquired+3,757–F2–94,304Direct
Aug 19, 2026Common SharesDReturned to the companyDisposed−3,757$8.94F3−$33,587.5890,547Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 19, 2026Common SharesMOption exerciseDisposed−15,029$0.00$00Direct
Aug 19, 2026Common SharesMOption exerciseDisposed−3,757$0.00$00Direct
Aug 17, 2026Common SharesAGrant or awardAcquired+12,174$0.00$012,174Direct
Aug 17, 2026Common SharesAGrant or awardAcquired+3,043$0.00$03,043Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

Referenced by the price of 1 transaction in Table I.

F2

Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

Referenced by the price of 1 transaction in Table I.

F3

Per share value is based on the market closing price of the common shares for August 19, 2026.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)